Compare AMLX & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMLX | SVM |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2021 | 2005 |
| Metric | AMLX | SVM |
|---|---|---|
| Price | $19.37 | $9.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $21.56 | $10.50 |
| AVG Volume (30 Days) | 1.6M | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-25-2026 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $36.87 |
| Revenue Next Year | N/A | $35.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $7.48 | $4.29 |
| 52 Week High | $20.90 | $15.77 |
| Indicator | AMLX | SVM |
|---|---|---|
| Relative Strength Index (RSI) | 59.66 | 44.06 |
| Support Level | $12.14 | $8.68 |
| Resistance Level | N/A | $10.19 |
| Average True Range (ATR) | 1.28 | 0.45 |
| MACD | 0.13 | 0.09 |
| Stochastic Oscillator | 68.10 | 47.93 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.